AstraZeneca is expecting a return to sales growth in 2018 as new medicines win market share

AstraZeneca expects drug sales growth in 2018 as new medicines win market share and the group puts patent losses behind it.
Source: CNBC

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>